Welcome!

We hope that this page gives you a sense of the kind of work that we are doing in our lab here, the PTSD Treatment and Research Program – and the opportunities for students that are available. Our work is focused on intervention studies, primarily in the area of PTSD, but also in mood disorders. We are a busy, productive group. We routinely work on various grants and chapters which relate to our mission statement. We also work with randomized controlled trial (RCT) datasets from studies our lab has completed with our collaborators across the country. Below are descriptions of our current research projects.

Positive Processes and Transition to Health

Positive Processes and Transition to Health (PATH) is an NIMH-funded clinical trial that is soon beginning recruitment. This is a multi-site trial in collaboration with the University of Washington and the University of Delaware. This project includes is an innovative treatment that targets maladaptive event processing (unproductive processing, avoidance, and anhedonia). PATH is an individual treatment program for adults suffering from depression and trauma-related symptoms and also promotes parallel adaptive event processing (constructive processing, approach, and reward seeking) for destabilizing life events (e.g., financial stress, illness, death of loved ones, stressful events due to the COVID-19 pandemic, termination of a significant relationship). PATH broadly addresses stressor-related psychopathology and therefore can treat PTSD alone, depression alone, the combination, and subthreshold distress, grief, and impairment.